The Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA) has updated the Vaccination Guidelines it offers to veterinary surgeons.
The association says its Canine and Feline Vaccination Guidelines aim to provide globally applicable recommendations to help veterinary surgeons vaccinate in a standard and scientifically justified fashion.
The VGG has also updated the vaccination guidelines it offers to pet owners and breeders, as well as the series of fact sheets it has created on key global vaccine-preventable diseases of dogs and cats.
The original guidelines were published in 2007 as the WSAVA's initial response to the need for globally applicable recommendations on vaccination best practice. They were updated in 2010 and, since then, the VGG, which is supported exclusively by MSD Animal Health, has been focusing on issues relating to small companion animal infectious disease and veterinary education in Asia.
The 2015 release of the Canine and Feline Vaccination Guidelines is based on a new evidence-based classification system for vaccinology. It also includes a number of additional FAQs (110 in total). The guidelines for both vets and owners/breeders are available for free download at http://www.wsava.org/educational/vaccination-guidelines-group. Currently available in English, they are being translated into a number of languages.
Professor Michael Day, Chair of the VGG (pictured right), said: "The vaccination guidelines are one of the most frequently downloaded resources on the WSAVA's website and are gradually driving a change in vaccination practice throughout the world - a change which is set to have a major impact on day-to-day small animal practice.
"We are delighted to launch these updated versions both for veterinarians and for pet owners and breeders. We hope they will prove even more helpful and ensure that more small animals are vaccinated in a more scientifically-based, robust and safer fashion.
"We would like to thank MSD Animal Health which has been the sole sponsor of the VGG since its inception. Its support enables us to undertake our valuable work."
Trilotab is licensed for the treatment of pituitary-dependent hypercortisolism (PDH) caused by an adrenocorticotrophic hormone (ACTH)-secreting pituitary adenoma, which accounts for 85% of spontaneous cases of Cushing’s, and for the treatment of adreno-dependent hyperadrenocorticism (ADH) caused by a cortisol-secreting adrenocortical tumour (ACT), which accounts for the remaining 15% of spontaneous cases1.
The new tablet is divisible into halves and quarters to facilitate dose adjustment and make administration easier.
Divided tablets remain stable outside of the blister packaging until the next dose is due, thereby avoiding wastage.
Trilotab tablets are chewable and chicken-flavoured to help improve treatment compliance.
They contain hydrolysed chicken flavouring so they can be prescribed for pets allergic to chicken.
Trilotab is administered once daily with food with a starting dose of 2mg trilostane/kg bodyweight.
The new tabs are available in three presentations: 10mg, 30mg, and 60mg presentations, which Virbac says should help practices reduce their dispensary stockholding.
Andrew Connolly, Marketing Director – UK & Ireland at Virbac, said: ‘The complex nature of Cushing’s syndrome in dogs can make it a challenging condition to manage for both the clinician and the pet owner.
"With the requirement for lifelong treatment, it is our hope that Trilotab’s easy administration and simplified dosing protocols will genuinely help to improve the lives of dogs affected by the disease, whilst making the clinician and pet owner’s lives just a little bit easier too!"
Reference
The company says the aim is to identify the most effective ways to minimise the risks this common and debilitating infectious equine virus poses. The survey can be found here.
Equine Herpes Virus is a contagious virus, which can cause respiratory disease, abortion and more rarely neurological disease. In addition, sub-clinical infections can be associated with a syndrome of poor performance and have a potential effect on the health of the whole yard.1
The disease is transmitted from horse to horse through the respiratory tract, by inhalation of the viral particles shed by infected horses. Once a horse is infected with Equine Herpes Virus it is likely to be latently infected for life. Viral reactivation and nasal shedding can occur at any time, particularly during stressful periods such as when mixing with other horses at equine events. This can lead to acute disease episodes. Often affected horses are asymptomatic but if they do show symptoms these may include depression, lethargy, pyrexia, nasal discharge and a dry cough. Reduction of shedding through management and vaccination is key to disease control.2
Wendy Talbot, National Equine Veterinary Manager at Zoetis said: "EHV has potentially serious health, performance and financial implications across every sector of the equestrian industry.
"The aim of our survey is to find out more about current vet protocols in practice. The results should help us to identify and then ensure that the most effective prevention strategies are accessible to vets and their clients."
The survey runs from 4 – 22nd March 2019 in parallel to a separate survey for horse owners.
For further information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
References
Phovia, which was launched in the UK last year, is a two-part FLE system consisting of a chromophore gel that is applied to the affected skin and a blue light LED lamp.
Vetoquinol says that when used together they produce light of varying wavelengths that penetrates the skin to different depths, helping to control bacteria and reduce inflammation on the surface of the skin and stimulating regeneration in the epidermal and dermal layers.
The unit is portable, and applications take four minutes once a week.
The authors of the Vetoquinol-funded study say that FLE has already been shown to support and accelerate natural skin healing, but this latest research shows that the benefits go beyond improvement in clinical signs.
The study looked at 35 dogs with a diverse range of skin conditions: 13 had interdigital furunculosis, 10 had deep pyoderma, 6 had wounds, 4 had pyotraumatic dermatitis, and 2 had perianal fistula on presentation.
Eight of 35 dogs were new cases, whereas the remaining 27 were undergoing recrudescence of a prior episode, including pyotraumatic dermatitis, wounds, deep pyoderma, interdigital furunculosis and perianal fistulae.
Thirty dogs (86%) achieved a clinical resolution: 18 with the Fluorescent Light Energy alone and 12 with the concomitant use of FLE and topical antiseptic shampoo.
Five dogs (14%) had a partial response and needed other therapies.
92% percent of owners attested to their pet’s enhanced quality of life, with 74% of dogs displaying at least a 50% improvement in owner-reported behaviour, mood, sleep and playing activities.
The study also reported a 46% reduction in caregiver burden.
Felicity Caddick, Technical Services Manager at Vetoquinol said: “Managing skin conditions often requires the long-term use of shampoos or topical therapies.
"Many owners find this aspect of pet ownership challenging, especially with larger dogs, or less cooperative animals.
"FLE can reduce or in some cases eliminate the need for topical therapies at home, not only simplifying the treatment process but also enhancing convenience and compliance.
"Sharing responsibility for administering ongoing treatment with their vet practice also removes some of the worry associated with their pet’s health.”
Vetoquinol also highlights that Phovia can offer vets a drug-free management option for skin disorders that aligns with the principles of antibiotic stewardship.
The outreach programme began earlier this month at the Devon County Show (pictured right), where the College used the opportunity to spread the word about its petsneedvets campaign, handing out over 1000 promotional bags in the process.
Next on the itinerary is the Royal Welsh Show near Builth Wells from the 23rd to 26th July. From there, the College will be heading to the BBC Countryfile Live event, held in the grounds of Blenheim Palace in Oxfordshire from the 2nd to 5th August.
Ian Holloway, Director of Communications at the RCVS, said: "Following the success and popularity of our stand at Countryfile Live over the past two years we decided that this year we would broaden our horizons and attend some of the UK’s most prestigious and well-attended regional events.
"We have our ever-popular careers materials available, and it was wonderful to see dozens of young people at the Devon County Show asking us about how they can become veterinary surgeons and veterinary nurses, as they always have the past two years at Countryfile. This is a really encouraging level of interest in the professions and we’re very happy to provide information to help them fulfil their aspirations.
"Attending more and different public events is a trend we are very keen on continuing with and we will be looking at other events to attend in different parts of the UK for next year."
For more information about upcoming events involving the RCVS visit www.rcvs.org.uk/events
Photo: Royal College of Veterinary Surgeons
The study, which was carried out by the VetCompass programme at the RVC, in partnership with Vets Now, also found that cats are most likely to be involved in a traffic accident in the autumn.
1,407 cat road traffic accident cases that attended Vets Now clinics across the UK between December 2011 and February 2014 were analysed, with researchers finding:
Younger cats, aged six months to six years, are at the greatest risk of road traffic accidents.
Male cats are 1.3 times more at risk of road traffic accidents than female cats.
Crossbred cats are 1.9 times more at risk of road traffic accidents compared to purebred cats.
Cats are more likely to be involved in a road traffic accident in the autumn. However, they are less at risk in winter as compared to spring.
Those cats that present with abdominal or spinal injuries are more likely to die, as are those that present with an increasing count of injuries.
RVC veterinary epidemiologist and VetCompass researcher Dr Dan O’Neill said: "One of the scariest times for any cat-owner is when they first start to let their cat go outside unattended. Owners of younger, and especially male, cats need to be especially vigilant. These results help owners to understand the true risks and therefore assist these owners to make the best decisions about if and how they let their cats go outside."
Dr Amanda Boag, Clinical Director of Vets Now, said: "We are very proud to have worked with VetCompass to ensure this important information about risks to our pet cats is made available to vets and the public. Working with our partners such as the RVC, we are committed to ensuring our large clinical database is used to help advance veterinary knowledge and understanding of emergency and critical care practice."
The full paper entitled 'Epidemiology of Road Traffic Accidents in Cats attending emergency-care practices in the UK' is published in the Journal of Small Animal Practice.
CEVA Animal Health's live enzootic abortion vaccine, CEVAC® Chlamydophila, has been renamed CEVAC® Chlamydia and repackaged in a larger bottle size.
According to the company, infectious abortion, particularly enzootic abortion (Chlamydiosis) can wipe out up to 50% of lambs but strategic use of CEVAC Chlamydia, a live enzootic abortion vaccine, can help keep the flock safe. It can prevent abortion and also control excretion and the threat of infection. For added convenience CEVAC Chlamydia can be used on the same day as the toxoplasmosis vaccine. This can save administration time and money.
For extra efficiency with big flocks CEVAC Chlamydia is now available in a larger, 50 dose bottle in addition to the original 20 dose bottle. It is administered using a special multi-dose injector gun.
CEVA says that a strategic vaccination every four years will help flocks remain chlamydiosis-free. Routine preventative measures are also advised prior to mating and when new sheep are introduced to the flock, to ensure abortion and infection rates always remain as low as possible. All animals should be vaccinated in the first year, with replacements being vaccinated from six months of age, at least four weeks prior to tupping.
For further product information contact your local CEVA representative or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG or visit the website at www.ceva.uk.com
The guide reviews the definition and classification of pyoderma, history-taking and clinical examination, and diagnostic testing techniques. It also reviews current thinking on therapy options. Bayer says it hopes the practical and evidence-based guide will be an invaluable resource in veterinary practices.
Ross said: "With pyoderma cases appearing almost daily in veterinary consultations, it is vitally important that vets are well versed in treating cases appropriately and efficiently, particularly to ensure the responsible use of antimicrobials. Canine pyoderma commonly poses diagnostic challenges, due to its varied clinical presentation and tendency to be super-imposed on other skin diseases. We envisage that the article will provide readily accessible, clear and practical advice on diagnosing and treating the condition."
Bayer has also launched a new Veraflox website, where the first and second guides in the Education Now, Safeguarding Antimicrobials series (written by Simon Tappin, Head of Medicine at Dick White referrals, Matt Jones, Head of Microbiology at IDEXX, and Ross Bond), are also available for download in the Vet Training Centre section.
The website also offers a number of other resources in the Vet Training Centre, including webinars, case studies and videos.
Hannah Watts, Group Product Manager at Bayer, said: "The new Veraflox website has been built with the practical needs of vets in mind. We hope this will become a frequent resource for helping them overcome daily challenges in diagnosing and treating cases with an appropriate antimicrobial product."
In addition to being available for download at www.veraflox.co.uk, Focus on Pyoderma is also available in print by contacting your Bayer Territory Manager.
The Blue Cross is offering a lifeline to even more needy pets across the UK following an extension to its successful veterinary grant scheme.
Relaunched as “The Blue Cross Veterinary Care Fund”, the charity has increased available funding and doubled the maximum grant it will pay towards veterinary costs of a particular treatment, operation or neutering procedure if the owner can't afford it.
The initiative was first launched in 2005 to help pet owners on low incomes who do not live near Blue Cross hospitals or clinics. So far the charity has awarded thousands of grants through 1,100 veterinary practices, 28% of all private vets in the UK. The demand from needy pets around the country prompted The Blue Cross to increase the maximum grant to £200 towards the veterinary treatment costs.
Pet owners must be on a means tested benefit or state pension with no other income to be eligible for support through the Veterinary Care Fund. Those on a very low income may also be eligible for the grant and should contact The Blue Cross for further advice.
The charity is also opening a new veterinary welfare clinic on 3 June 2008. The clinic, based at the animal adoption centre in Tiverton, will carry out basic procedures such as microchipping and vaccinations, and treat minor ailments. More serious or complicated cases will be referred to a local veterinary practice where treatment will be subsidised by The Blue Cross.
For more information about the Veterinary Care Fund or how clients can apply please contact The Blue Cross customer care team on 01993 825593 or email info@bluecross.org.uk
Royal Canin has launched a range of new renal diets to help support cats and dogs with Chronic Kidney Disease (CKD).
According to the company, CKD patients are twice as likely to show signs of anorexia, food intolerance and loss of appetite than non-CKD pets, so the focus with the new diets has been on different aromatic profiles, textures and tastes to provide choice and encourage feeding without compromising the nutritional management of the pets with CKD.
Royal Canin says each of the diets in the new Renal range has been developed with a unique aromatic profile, so that cats and dogs can be attracted to their food bowl even after an episode of food aversion.
The new range also provides two different textures of dry diet for both cats and dogs. In addition to the classic kibbles found in Renal and Renal Special, the new Renal Select diet for cats has a pillow kibble with a thin, crunchy shell and a soft centre for cats who used to love crunching but are beginning to struggle with harder kibbles. The new kibbles for dogs are designed to be easy to rehydrate, providing the taste of a dry diet in a softer, easier to chew format. A new Renal Wet range is also available with a 'loaf' or 'chunks-in-gravy' texture and these can be combined with any dry diet to allow even greater variety of textures.
With CKD causing frequent fluctuations in an animal's sense of taste, Royal Canin has made the feline range available in smaller 500g bags, making it easier for owners to swap between the differing options as their pet's tastes alter.
Royal Canin's Veterinary Marketing Manager, Marianne Lomberg, said: "The efficiency of a renal diet depends upon it being fed on a continuing basis and so our new range provides a complete range of aromatic profiles and textures to keep your CKD patients enjoying every meal without compromising on their nutritional management. Royal Canin has a proven track record of developing innovative diets to help pets, and the new Renal Diets are an exciting new move for us."
Royal Canin is also offering a 'patient compliance guarantee' where vets and their clients can claim their money back if a pet does not like any of the many diet combinations offered by the range.
Equipalazone is most commonly used to treat lameness in equines and can be prescribed as a treatment for osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis as well as to reduce post-surgical soft tissue reaction.
The new apple-flavoured version, which contains no added sugar, is presented in 1.5g sachets which are added to feed. The existing unflavoured product is still available as Equipalazone Original.
Dechra Brand Manager Emma Jennings said: “The new apple flavoured Equipalazone is the same tried and trusted popular product that vets have been using for many years but the enhanced apple flavour should improve compliance amongst even the fussiest of feeders.
"Equipalazone has been a best-selling treatment delivering powerful pain relief since we brought it to the market as the first microencapsulated phenylbutazone more than 45 years ago. The new apple flavoured presentation will give vets even more choice when it comes to providing pain relief and anti-inflammatory treatment for equine conditions."
For more information visit www.dechra.co.uk.
Dr Mostert admitted to his conviction but denied that it rendered him unfit to practise as a veterinary surgeon.
He also admitted not disclosing his conviction to the RCVS but denied that it amounted to dishonesty or was misleading and that failing to do so amounted to disgraceful conduct in a professional respect.
The Committee first considered whether Dr Mostert’s conviction affected the public interest, which included the need to maintain public confidence in the profession by upholding proper standards of conduct and behaviour for members of the profession.
The Committee noted that the conviction involved dishonesty relating to false statements about the value of goods sent to the USA.
The Committee felt that a conviction for a serious offence involving dishonesty would have a negative impact on public confidence in the profession, and that its reputation would be damaged if proper standards of conduct and behaviour were not upheld.
The Committee also noted that as the products that Dr Mostert imported into the USA were not labelled as coming from a foreign market and were not labelled as needing to be administered by a vet, his conviction also related to animal safety, as anyone who accessed the medications could believe that it was safe for them to be given to an animal.
The Committee then considered Dr Mostert’s failure to declare the conviction to the College on three separate occasions.
Dr Mostert testified that, at the time, he did not believe he had to disclose his conviction as it occurred in a country where he had not practised as a veterinary surgeon.
He also said he had not taken the time to read and interpret the application form accurately.
However, the Committee considered that the wording around convictions on the application and annual renewal forms is very clear and that, as a veterinary surgeon, Dr Mostert would be familiar with such documents.
The Committee considered that it was inconceivable that an experienced veterinary surgeon, making a declaration of this kind to his regulator, would not have understood that a serious conviction in the USA, dating from June 2017, was a conviction that he was obliged to disclose.
The Committee therefore found Dr Mostert’s failures to declare his conviction dishonest.
Judith Way, Chairing the Committee and speaking on its behalf, noted that in deciding upon the appropriate sanction, the case did not involve any actual harm to an animal or human and that Dr Mostert had had a long and otherwise unblemished career.
However, a key aggravating factor was that the action that led to the conviction resulted in financial gain through the creation of a business enterprise and that Dr Mostert falsely declared the value of goods.
The extent of any financial gain was not known to the Committee, but the business operated on the basis that false declarations were repeatedly made.
Judith said: “After careful consideration the Committee has concluded that in all the circumstances, a lengthy period of suspension would properly reflect the gravity of the case and satisfy the public interest. The Committee has decided that the appropriate length of suspension is one of 18 months.”
The Committee’s full findings can be viewed at www.rcvs.org.uk/disciplinary
The Elsevier publication is edited by Dottie Laflamme, DVM PhD ACVIM (Nutrition) with an expert team of authors providing practical information on a variety of nutrition topics appropriate for daily practice. https://bit.ly/PurinaEBook2
The Elsevier publication is designed to help veterinary staff expand their knowledge and skills in nutrition topics, from discussing nutrition with clients, to the nutritional management of common health conditions, so that they can be confident in their own nutrition knowledge and ability to communicate about nutritional issues.
The current edition, edited by Dottie Laflamme, DVM PhD ACVIM (Nutrition), is available in English and in Spanish.
Daniel Rodes DVM, PhD, and regional leader for the Purina Institute, said: “The veterinary team is a valued source of nutrition information for pet owners, but vets do not always initiate discussions about nutrition with clients for various reasons, including the concern that owners may be unwilling to change their views on their choice of a pet’s diet1.
"In fact, one recent study reported that most veterinary clients (93%) 'were at least somewhat willing to change their pet’s diet on the basis of a veterinarian’s recommendation if it was phrased as benefiting their pets’ health'2, and in another, the veterinary healthcare team was reported to be the primary (43.6%) and most important source of nutrition information for pet owners3".
Although most articles cover nutrition for dogs and cats, there is also a review on nutrition for ferrets, rabbits and rodents, and another on effective communication, suggesting ways veterinary teams can empower clients to take positive action to support the health of their pets.
https://bit.ly/PurinaEBook2
The announcement came hot on the heels of announcements from Ceva and Boehringer that they too had vaccines in the pipeline.
Syvazul BTV3 is licensed to reduce viraemia, prevent mortality and reduce clinical signs and lesions in sheep and for the active immunisation against bluetongue virus serotype 3 in cattle.
Like all vaccines currently available for this serotype, the vaccine will not prevent infection and vaccinated animals will still be subject to bluetongue movement controls and trade restrictions currently in place.
Administered as a single 2ml dose subcutaneously in sheep and as two 4ml intramuscular doses 3 weeks apart in cattle, Syvazul BTV3 contains inactivated Bluetongue virus, serotype 3 (BTV-3), strain BTV-3/NET2023.
The vaccine is licenced for use during pregnancy and lactation in both sheep and cattle.
The onset of immunity is 28 days after the primary vaccine in sheep. A single booster revaccination dose of 2ml for sheep and 4ml for cattle is recommended after 12 months.
Presented in two pack sizes, 80ml and 200ml, Syvazul BTV3 vaccine has a shelf life of 2 years from manufacture and a broach life of 10 hours.
Licensing for use will be geographic, based upon high risk counties or by specific licence from the APHA.
Companion Care has opened its 80th surgery, within the Ilford Pets at Home store.
Companion Care Vets managing director, Jane Balmain said: "The opening of our 80th surgery proves the success of our joint venture partner business model. At present the majority of our surgeries are located inside Pets at Home stores but we also have four very successful standalone surgeries. Our standalone surgery network is now being developed to create further exciting opportunities for future growth, with our first new standalone surgery opening in Scotland this December."
Joint venture partner and veterinary surgeon at Companion Care Vets Ilford Alberto Arciniega said: "Alongside the fantastic team we have on board, my partners Nick and Claire and I are extremely proud to be opening our second surgery here in Ilford. Having been partners at the Romford surgery since July 2009 we have seen the company grow consistently and successfully. We feel honoured to be opening the groups' 80th surgery and look forward to the challenge of managing both practices and to delivering outstanding veterinary care."
With 102 Joint Veterinary Partners, 83 of whom are veterinary surgeons, 12 veterinary nurses, 6 practice managers and 1 receptionist and a further 789 staff employed by the group Companion Care Vets is one of the largest veterinary employers in the UK. Dividend payments to joint venture partners in the 2010/2011 period totalled £2.181 million and the group says it plans to open a further 10 surgeries across the UK before the end of year.
Dunhelm Veterinary Group in Durham has been targeted by an unusual protest, parked outside its front door.
According to a report in the Northern Echo, the van appeared outside the practice last Saturday.
One of the partners, Jack Creaner told the newspaper that there were no outstanding complaints against the practice and the protest was unexplained.
Although the van has now gone, the practice still has no idea who was behind the protest. However, it does seems to have backfired spectacularly, unleashing a wave of support on the practice's Facebook page: https://www.facebook.com/pages/Dunelm-Veterinary-Group/299184546875132
Jack said: "We are very grateful to all the people who took time to make such lovely remarks on social media."
He added the following advice for anyone else who in the profession who finds themselves at the receiving end of this kind of behaviour: "Try not to let these things get to you on a personal level. As we saw lots more people like what we do than don't. As one client put it - you can be the ripest sweetest juiciest peach in the world but someone out there doesn't like peaches."
The marketing pack includes a poster, leaflet and a counter top display which highlight the stress factors facing pets and provide pet owners with an overview of how Feliway and Adaptil help pets cope with challenging situations.
Ceva will also be running a competition for pet owners to win £150 of John Lewis vouchers in a prize draw. To enter, they need to email cevauk@ceva.com with the subject 'Stress Free Christmas' and their name and contact number. The competition closes on 24 December 2017 and the winner will be contacted by telephone in January 2018.
Claire Russell, brand manager at Ceva Animal Health, said: "Big family gatherings, noisy toys and being home alone more often are just some of the stressful situations that pets can find themselves in during the festive period. Our new marketing pack will help highlight these stress factors amongst pet owners and raise awareness of how Feliway and Adaptil can help support their pets."
To request a Christmas marketing pack, contact your Ceva Animal Health account manager, email cevauk@ceva.com or contact customer services on 01494 781510.
The new products are:
Leon Wright, Managing Director, said: "At Vet Direct, we’re always looking for ways to improve our service – making small changes which will have a big impact on the levels of care our clients can provide.
"We know that vets, veterinary nurses and practice managers don’t always have the time to try out new products before purchasing, and that’s why our dedicated team of sales staff test every item before adding them to our catalogue - ensuring that we only stock the highest quality products."
For more information on any of the new products, visit www.vet-direct.com or call 0800 068 3300.
Janssen Animal Health has launched Domosedan Gel, an oromucosal gel for the sedation of horses.
Janssen says Domosedan Gel, which contains 7.6 mg/ml (40mcg/kg) detomidine, induces sedation and analgesia with the efficacy and recovery comparable to Domosedan injection. Domosedan Gel is administered under the horse's tongue, so it is rapidly absorbed.
The company also says Domesedan Gel can replace physical restraint and improve safety during treatments, diagnostics and transport, and that the gel is ideal for horses that are nervous or needle-shy and when owners need more control during clipping, shoeing, dental treatments and boxing.
Nicki Glen, marketing manager at Janssen Animal Health said: "Domosedan Gel is proven to be both effective and easy-to-administer with 98% of horses accepting the gel and owners finding it easy and convenient to use.
"The gel starts to be absorbed immediately and demonstrates a reliable sedatory effect and high safety margin, making it an ideal solution for sedation and restraint when performing non invasive procedures on horses."
For further information, please contact your Janssen Animal Health territory manager.
Ceva Animal Health has launched Cardio Academy. The company says it's the first international cardiology e-learning programme offering CPD from leading international specialists.
The programme can be accessed at www.cardioacademy.cevalearn.com. It consists of a series of impressively well-produced interactive multimedia presentations lasting around 30 minutes, at the end of which you can download a CPD certificate.
The first two sessions, which are now available online, cover the Pathophysiology of Mitral Valve Disease, by Adrian Boswood, and Clinical Examination of the Cardiac Dog, by Gérard Le Bobinnec.
Product manager, Fraser Broadfoot MRCVS, said: "There have been many advances in the diagnosis and treatment of heart failure in recent years. The aim of this website is to become a practical and up-to-date resource on the management of heart failure in practice."
All Schedule 2 controlled drugs (with the exception of quinalbarbitone) and certain Schedule 3 controlled drugs are legally required to be stored in a locked container which is compliant with the Misuse of Drugs (Safe Custody) Regulations 1973; however, the College considers it advisable for all Schedule 3 controlled drugs to be stored in the controlled drug cabinet.
Controlled drug cabinets must only be accessed by a veterinary surgeon, or another nominated responsible person at the practice. In the case of a nominated person who is not a veterinary surgeon removing controlled drugs from the cabinet, the legal and professional responsibility remains with the veterinary surgeon whose direction they are under.
The College’s full guidance, including advice on use, location, and design and construction of cabinets, can be found in the Controlled Drugs Guidance and the Practice Standards Scheme Manual. Many police forces in the UK also have Controlled Drugs Liaison Officers who offer advice on various matters, including safe storage.
To download the Controlled Drugs Guidance, which includes further guidance on areas such as storage and destruction of controlled drugs, please visit the College’s website: http://www.rcvs.org.uk/publications/controlled-drugs-guidance/
To access the PSS Manual, visit the College’s website: http://www.rcvs.org.uk/practice-standards-scheme/
Contact details for Controlled Drugs Liaison Officers by area can be obtained from the Association of Police Controlled Drugs Liaison Officers: http://www.apcdlo.org.uk/contact.html.
The study1 suggests that dogs with uncomplicated diarrhoea do not need antibiotics as part of their veterinary care plans.
The study included a random sample of 894 dogs aged between three months and 10 years old diagnosed with uncomplicated diarrhoea in 2019.
Of these, 355 (39.7%) dogs were prescribed antibiotics, and 539 (60.3%) dogs were not prescribed antibiotics (with or without additional supportive treatment) at first presentation for diarrhoea.
For the analysis, the dogs were balanced for a range of other differences between the groups including age, breed, bodyweight, insurance status, the presence of two or more medical conditions, vomiting, reduced appetite, blood in faeces, raised temperature, duration of diarrhoea, additional treatment prescription and veterinary group.
The researchers say this effectively meant that the only difference between the two groups was that one group received antibiotic treatment while the other did not.
The likelihood of clinical resolution of diarrhoea in the dogs prescribed antibiotics was 88.3%, compared with 87.9% in dogs not prescribed antibiotics.
This tiny difference of 0.4% between the groups was not statistically significant, leading to the conclusion that antibiotic treatment did not cause any beneficial effects in the treatment of uncomplicated diarrhoea in dogs.
Almost nine in 10 dogs with uncomplicated diarrhoea recovered after a single veterinary visit regardless of antibiotic treatment.
As an additional analysis, the study also explored gastrointestinal nutraceuticals (products derived from food sources that aim to restore digestive health such as probiotics and prebiotics) for treatment of uncomplicated diarrhoea in dogs.
Gastrointestinal nutraceutical prescription (with or without other supportive treatment) at first presentation of uncomplicated diarrhoea caused no statistically significant difference in clinical resolution compared to dogs not prescribed gastrointestinal nutraceuticals.
Camilla Pegram, VetCompass PhD student at the RVC and lead author of the paper, said: “This study used an exciting new approach that allowed us to determine ‘cause’ rather than being limited to ‘association’.
"Diarrhoea is a common condition in dogs and is often treated with antibiotics.
"However, this study highlighted that antibiotic prescription at first presentation of diarrhoea caused no difference in clinical resolution.
"Therefore, this arms veterinarians with the evidence-base for restricting antibiotics for uncomplicated diarrhoea in dogs, and owners should be prepared to only have an antibiotic prescription if absolutely necessary.”
Fergus Allerton, project lead for the PROTECT ME guidelines and co-author of the paper said: “Rational antimicrobial use is critical to defend ourselves and our pets against the growing threat from antimicrobial resistance.
"This study provides vital evidence to strengthen recommendations to withhold antibiotics when treating dogs with acute diarrhoea. Knowing that the outcome will be the same without antibiotics should reassure veterinarians to adopt this approach consistently.”
Stephen, who works for the PDSA, wowed the judges with his photograph of a pair of wild ponies, entered into the 'All creatures great and small' category. He said: "I had a great day out photographing these wild grey ponies on a similarly grey January dayon the Long Mynd, a heath and moorland plateau in the Shropshire hills. I was simply out on a photo walk to take in the scenery and wildlife, look for a good shot and get a breath of fresh air; I’m chuffed that the judges have selected it as a category winner!"
Peter, who graduated from Nottingham University this summer and works at a practice in Bicester, won in the ‘Human:animal bond’ category with his entry: 'Best part of a job', which shows a laid-back 10-week-old cocker spaniel puppy lounging contentedly on his lap. Peter said: "This photo was taken whilst on placement in Chipping Norton as a student. The puppy was in to have her second vaccinations and a general health check after she had been with her new family for a week, and she was on my lap so that I could calm her, examine her, and socialise her. Working in the veterinary world is by no means easy, which is why moments like this are so important. Everyone needs a puppy cuddle!"
This year, the judging panel included David Tipling, one of the world's most widely published wildlife photographers. He said: "Helping to judge this year’s competition was for me a fascinating insight into a vet’s working life. Photography, like any art form, is subjective, but I was looking for pictures that had been composed and thought about and most importantly would linger in the mind long after they had been viewed. Much debate and discussion led us to some clear favourites from which to choose two overall winners."
"The winning shot [by Stephen] is beautifully composed, has a symmetry and used the dark and light tones of the ponies to complement each other, resulting in a striking image that we were all drawn to. I was drawn to [Peter’s] image partly by its abstract nature; on first view it is not obvious the dog is on someone’s lap. It is a strong, engaging image and because of that slightly abstract feel means it stays long in the memory.”
Peter and Stephen each receive £250 worth of gift vouchers from John Lewis.
Saliva was collected from 237 horses at the UK welfare charity, Bransby Horses, where EquiSal Tapeworm saliva testing was used to inform on anthelmintic administration over the course of a year. This diagnostic-led approach reduced the use of anti-tapeworm treatments by 86% compared to 6 monthly interval treatment strategies.
Austin Davis Biologics Ltd, the maker of the EquiSal Tapeworm saliva test, says it accurately diagnoses horses with a tapeworm infection, providing a low, borderline or moderate/high diagnosis.
Treatment is recommended for horses with a borderline or moderate/high result2.
In this latest study, the company says most horses diagnosed below the treatment threshold in the first saliva test remained below the threshold in the following two tests and 168 horses (71%) required no anti-tapeworm treatment at all.
Importantly, no increase in tapeworm infection prevalence was observed during the study period and only seven horses received treatment following all three saliva tests, suggesting that some horses are more susceptible to tapeworm infections.
The EVJ has prepared a podcast summarising the study findings here: https://evj.podbean.com/e/evj-of-the-hoof-podcast-no-1-march-2018-use-of-saliva-based-diagnostic-test-to-identify-tapeworm-infection-in-horses-in-the-uk/.
The study authors have also prepared a video abstract which can be viewed at https://vimeo.com/254338616 .
EquiSal saliva collection kits are available at trade prices to veterinary practices and SQPs. Contact enquiries@equisal.com or visit www.equisal.com for more information.
The awards, which have in the past recognised the welfare achievements of veterinary surgeons, nurses and animal welfare professionals, will this year also recognise farming professionals. There is also a new award for an 'Outstanding Contribution to Animal Welfare'.
The award categories include:
Chris Laurence Vet of the YearDedicated to the head judge, Christopher Laurence, in recognition of a veterinary surgeon (either companion or farm animal) who demonstrates their commitment to the continuous improvement of animal health and welfare.
Vet Nurse of the YearAn award for a veterinary nurse (either companion or farm animal) who excels in their role by demonstrating and/or educating to the highest level of animal health and welfare.
Charity Team of the YearFor an inspiring team whose drive and passionate dedication has changed the lives of animals for the better.
Charitable Contribution of the Year – sponsored by Blue CrossFor an individual, in either a voluntary or paid role, who is constantly committed to making a difference to animal welfare.
International Cat Care Welfare of the Year – sponsored by International Cat CareFor an individual who has made a significant contribution to the development of feline welfare. The winner of this award is selected by International Cat Care and therefore this category is not open to nominations.
Farmer of the YearFor a farmer who strives to provide and encourage a high standard of animal welfare on their farm(s).
Farm Educator of the Year – sponsored by NADISTo acknowledge the work of a SQP, advisor, university or other educational institute, that works hard to research and educate on the importance and benefits of farm animal welfare.
Outstanding Contribution to Animal Welfare – sponsored by Your Dog and Your Cat magazinesThis award is for an individual or team who stands out from the crowd by influencing and significantly contributing to making a visible difference in the world of animal welfare. This award is selected by our judging panel, from all nominations received for 2019 and therefore, this category is not open for direct nominations.
If there is a veterinary surgeon, veterinary nurse, farmer, animal welfare professional or animal welfare team that you feel deserves to be recognised for their ongoing commitment to animal welfare, visit www.cevawelfareawards.com to nominate. Entries must be in by Friday 11th January 2019.
The winners and runners up will be honoured at a glittering ceremony taking place on the eve of BSAVA Congress on 3rd April 2019.